arqule
MSD set to acquire ArQule in deal worth up to $2.7 billion
December 10, 2019Manufacturing and Production, Medical Communications, Sales and Marketing MSD, acquisition, arqule, pharma
MSD has revealed its intention to acquire biopharma firm ArQule in a deal worth a potential total of $2.7 billion, …
Daiichi’s lung cancer drug progresses to phase III
August 5, 2010Research and Development Daiichi, arq 197, arqule, lung cancer, phase III
Daiichi Sankyo and biotech firm Arqule are to move their lung cancer treatment ARQ 197 into phase III trials. The …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
Highlighting the value of lab research for healthcare innovation
November 2, 2026
